Cargando…
In silico analysis of a therapeutic target in Leishmania infantum: the guanosine-diphospho-D-mannose pyrophosphorylase
Leishmaniases are tropical and sub-tropical diseases for which classical drugs (i.e. antimonials) exhibit toxicity and drug resistance. Such a situation requires to find new chemical series with antileishmanial activity. This work consists in analyzing the structure of a validated target in Leishman...
Autores principales: | Pomel, S., Rodrigo, J., Hendra, F., Cavé, C., Loiseau, P.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
EDP Sciences
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671423/ https://www.ncbi.nlm.nih.gov/pubmed/22314241 http://dx.doi.org/10.1051/parasite/2012191063 |
Ejemplares similares
-
Minor Impact of A258D Mutation on Biochemical and Enzymatic Properties of Leishmania infantum GDP-Mannose Pyrophosphorylase
por: Mao, Wei, et al.
Publicado: (2022) -
GDP-Mannose Pyrophosphorylase: A Biologically Validated Target for Drug Development Against Leishmaniasis
por: Pomel, Sébastien, et al.
Publicado: (2019) -
Biochemical analysis of leishmanial and human GDP-Mannose Pyrophosphorylases and selection of inhibitors as new leads
por: Mao, Wei, et al.
Publicado: (2017) -
Trypanosoma cruzi Phosphomannomutase and Guanosine Diphosphate-Mannose Pyrophosphorylase Ligandability Assessment
por: Zmuda, Filip, et al.
Publicado: (2019) -
Alkyl-Resorcinol Derivatives as Inhibitors of GDP-Mannose Pyrophosphorylase with Antileishmanial Activities
por: Levaique, Hélène, et al.
Publicado: (2021)